Legal Representation
Attorney
F. Michael Sajovec
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 29, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 29, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 3, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 29, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 13, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 30, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 30, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 8, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 8, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 8, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 25, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 25, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 8, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 6, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 6, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 23, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 28, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 28, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 8, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 17, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 10, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 10, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 10, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 10, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 10, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 9, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 21, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 20, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, protein kinase inhibitors
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"